129 related articles for article (PubMed ID: 6380842)
1. Isolation and analysis of circulating immune complexes in leprosy.
Ramanathan VD; Parkash O; Ramu G; Parker D; Curtis J; Sengupta U; Turk JL
Clin Immunol Immunopathol; 1984 Sep; 32(3):261-8. PubMed ID: 6380842
[TBL] [Abstract][Full Text] [Related]
2. Circulating immune complexes in leprosy sera: demonstration of antibodies against mycobacterial glycolipidic antigens in isolated immune complexes.
Yamashita JT; Cruaud P; Papa F; Rotta O; David HL
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):44-50. PubMed ID: 8326180
[TBL] [Abstract][Full Text] [Related]
3. Specific and nonspecific aspects of humoral immune response in leprosy.
Kirsztajn GM; Nishida SK; Silva MS; Lombardi C; Ajzen H; Pereira AB
Braz J Med Biol Res; 1994 Jan; 27(1):43-54. PubMed ID: 8173529
[TBL] [Abstract][Full Text] [Related]
4. Influence of in vitro administered immune complexes on serum levels of complement and circulating immune complexes in Mycobacterium leprae infected mice.
Vaishnavi C; Ganguly NK; Kaur S; Singh M; Kumar B
Indian J Exp Biol; 1988 Jan; 26(1):9-12. PubMed ID: 3042618
[No Abstract] [Full Text] [Related]
5. Humans respond predominantly with IgM immunoglobulin to the species-specific glycolipid of Mycobacterium leprae.
Young DB; Dissanayake S; Miller RA; Khanolkar SR; Buchanan TM
J Infect Dis; 1984 Jun; 149(6):870-3. PubMed ID: 6376654
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin class specific antibodies to M. leprae in leprosy patients, including the indeterminate group and healthy contacts as a step in the development of methods for sero-diagnosis of leprosy.
Melsom R; Harboe M; Myrvang B; Godal T; Belehu A
Clin Exp Immunol; 1982 Feb; 47(2):225-33. PubMed ID: 7042137
[TBL] [Abstract][Full Text] [Related]
7. [Immune complexes and complement in leprosy (author's transl)].
Geniteau M; Adam C; Verroust P; Pasticier A; Saimot G; Coulaud JP; Languillon J
Nouv Presse Med; 1981 Dec; 10(45):3697-700. PubMed ID: 7322902
[TBL] [Abstract][Full Text] [Related]
8. [Circulating immune complexes in lepromatous leprosy patients].
Kuzina ZA; Mezhova LI; Vilkov GA; Khasabov LM
Vestn Dermatol Venerol; 1983 May; (5):11-4. PubMed ID: 6349167
[No Abstract] [Full Text] [Related]
9. Class-specific immunoglobulins and antibodies to mycobacterial sonicates and autoantigens in leprosy patients and contacts.
Mathew JM; Muthukkaruppan V
Microb Pathog; 1993 Nov; 15(5):367-76. PubMed ID: 8015417
[TBL] [Abstract][Full Text] [Related]
10. Leprosy reactions: humoral and cellular immune responses to M. leprae, 65kDa, 28kDa, and 18 kDa antigens.
Mohanty KK; Joshi B; Katoch K; Sengupta U
Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):149-58. PubMed ID: 15301588
[TBL] [Abstract][Full Text] [Related]
11. Relation between anti-Mycobacterium leprae antibody activity and clinical features in borderline tuberculoid (BT) leprosy.
Touw Langendijk EJ; van Diepen TW; Harboe M; Belehu A
Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):305-11. PubMed ID: 6358061
[TBL] [Abstract][Full Text] [Related]
12. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies.
Czerkinsky C; Koopman WJ; Jackson S; Collins JE; Crago SS; Schrohenloher RE; Julian BA; Galla JH; Mestecky J
J Clin Invest; 1986 Jun; 77(6):1931-8. PubMed ID: 3711340
[TBL] [Abstract][Full Text] [Related]
13. Reduced complement-mediated immune complex solubilization in leprosy patients.
Ramanathan VD; Sharma P; Ramu G; Sengupta U
Clin Exp Immunol; 1985 Jun; 60(3):553-8. PubMed ID: 3874729
[TBL] [Abstract][Full Text] [Related]
14. IgM and IgG antibodies to phenolic glycolipid I from Mycobacterium leprae in leprosy: insight into patient monitoring, erythema nodosum leprosum, and bacillary persistence.
Levis WR; Meeker HC; Schuller-Levis G; Sersen E; Schwerer B
J Invest Dermatol; 1986 May; 86(5):529-34. PubMed ID: 3528312
[TBL] [Abstract][Full Text] [Related]
15. Activation of complement by circulating immune complexes isolated from leprosy patients.
Tyagi P; Ramanathan VD; Girdhar BK; Katoch K; Bhatia AS; Sengupta U
Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):31-8. PubMed ID: 2319186
[TBL] [Abstract][Full Text] [Related]
16. Characterization of circulating immune complexes in leprosy patients and their correlation with specific antibodies against Mycobacterium leprae.
Rojas RE; Segal-Eiras A
Clin Exp Dermatol; 1997 Sep; 22(5):223-9. PubMed ID: 9536543
[TBL] [Abstract][Full Text] [Related]
17. Identification of components of IC purified from human sera. II. Demonstration of mycobacterial antigens in immune complexes isolated from sera of lepromatous patients.
Chakrabarty AK; Maire M; Saha K; Lambert PH
Clin Exp Immunol; 1983 Feb; 51(2):225-31. PubMed ID: 6340869
[TBL] [Abstract][Full Text] [Related]
18. A sequential study of circulating immune complexes, complement and immunoglobulins in borderline tuberculoid leprosy patients with and without reactions.
Ramanathan VD; Thyagi P; Ramanathan U; Katoch K; Ramu G
Indian J Lepr; 1998; 70(2):153-60. PubMed ID: 9724850
[TBL] [Abstract][Full Text] [Related]
19. Reciprocity between Regulatory T Cells and Th17 Cells: Relevance to Polarized Immunity in Leprosy.
Sadhu S; Khaitan BK; Joshi B; Sengupta U; Nautiyal AK; Mitra DK
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004338. PubMed ID: 26751584
[TBL] [Abstract][Full Text] [Related]
20. Suppressive effect of circulating immune complexes from leprosy patients on the lymphocyte proliferation induced by M. leprae antigens in healthy responders.
Tyagi P; Patil SA; Girdhar BK; Katoch K; Sengupta U
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):562-9. PubMed ID: 1299711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
